| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |